🔗 Share this article TikTok Influencers Fueling Unofficial Trade for Unlicensed Slimming Drug An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations. Investigational Drug Acquiring Popularity Online The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these accounts privately for supplier links, while also obtaining promotional offers. Active Trade on Messaging Platforms Separately, a flourishing trade exists on messaging services, where groups with numerous of members share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before directing buyers to other platforms for transactions. Understanding The Experimental Drug Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic. Medical Experts Voice Concerns Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering substances of unknown origin. Some professionals said the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro. Regulatory Position and Enforcement Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations. Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, advertising, and customer regulations, risking fines, legal action or prison. Platform Response and Content Elimination According to the social media company, the service has taken down problematic material and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the service secure and investing in strengthening compliance measures. Digital Trading Operations Research also found communities with up to 9,000 members selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of users, populated with photos of weight loss, glowing reviews and step-by-step guides for preparing or injecting at residence. After moments of joining one community, a seller posted contact information, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience. Product Information and Pricing Inside these groups, posts show black plastic parcels with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”. Platform Oversight and Security Actions A spokesperson for Telegram stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Medical Expert Cautions “Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained. Her staff has already encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.” Manufacturer Statement A representative from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose users to potentially serious medical dangers”.